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Abstract
Omega-3 polyunsaturated fatty acids, such as docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA), are known by their anti-inflammatory effects through 
mechanisms such as formation of specialized pro-resolving mediators (SPM), and 
more recently a new mechanism dependent on the free fatty acid (FFA) receptors 
has been studied. DHA and EPA have shown an effect on the release of prosta-
glandins (PGs) E2 and F2α in endometrial cells, two PGs that have key function in 
fertility. In addition, other molecules such as cyclooxygenase-2, IL-1β, NF-κB, and 
intracellular signaling pathways are also affected by omega-3 fatty acids in endome-
trial cells. In this chapter, we will expose the following issues: eicosanoids in fertility 
and immune function in the uterus, effect of omega-3 fatty acids on endometrial 
function: in vivo and in vitro studies, mechanisms of action of omega-3 fatty acids 
in endometrial cells, and perspectives in health and diseases.
Keywords: omega-3 fatty acids, prostaglandin, endometrial cells, fertility,  
immune function
1. Introduction
Uterine function is key for a suitable reproductive performance and fertility. 
Endocrine and immune response play important roles for keeping the hormonal 
levels and the fetal-maternal interface. Hormones such as estrogen and progester-
one are released from the ovaries; estrogen release is triggered by the hypothalamic-
pituitary axis, and progesterone is secreted from the corpus luteum (CL) after 
ovulation. Estrogen is essential for uterine growth and cell proliferation and proges-
terone for endometrial receptivity and successful establishment of pregnancy [1, 2]. 
Estrogen and progesterone are also considered as regulators of innate immunity and 
inflammation in the endometrium [3]. Endometrial immune homeostasis plays an 
important role in the success of implantation and pregnancy, with complex interac-
tions between the innate and adaptive immune system, through cells such as natural 
killer, antigen-presenting cells (macrophages and dendritic cells), and subtypes of 
T cells [4].
Prostaglandins (PGs), also known as prostanoids, are bioactive lipids with an 
important function as regulators of reproductive processes, including ovulation, 
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fertilization, and implantation. PGs are synthesized from arachidonic acid by 
different cells, and five types of PGs have been described, with specific roles and 
mechanism in the female reproductive system [5, 6]. Prostaglandin F2α (PGF2α) 
has a luteolytic effect, whereas prostaglandin E2 (PGE2) is central in ovulation, 
fertilization, embryo development, and implantation [7, 8]. In addition, PGE2 
plays important roles in inflammatory processes, being increased at first phases of 
inflammation [9].
Inflammation is a complex process with two differentiated steps or conditions: 
acute and chronic inflammation. A number of lipid mediators act as pro-inflamma-
tory (i.e., leukotriene and prostaglandins) or anti-inflammatory and pro-resolving 
(lipoxins, resolvins, maresins, and protectins) mediators. Lipid mediators derived 
from polyunsaturated fatty acids (PUFA) have potent anti-inflammatory effect 
and promote the resolution of inflammation, through specialized pro-resolving 
lipid mediators (SPM) [10]. Omega-3 fatty acids are a type of PUFA with known 
beneficial effect, which, in addition to its pro-resolving mechanism, have shown 
two additional anti-inflammatory mechanisms: activation of the free fatty acid 
(FFA)-4 receptor and inflammasome inhibition. Recent evidences have suggested 
an anti-inflammatory effect of docosahexaenoic acid (DHA) and eicosapentaenoic 
acid (EPA) in the endometrium. Furthermore, FFA4 receptor was detected in the 
human, mouse, and bovine uterus [11, 12]. The following sections describe the 
effect and potential mechanisms of omega-3 fatty acids in the immune cells and 
endometrium and perspectives of these fatty acids in health and disease.
2. Eicosanoids in fertility and immune function in the uterus
Eicosanoids, which include prostaglandins and leukotrienes, are members of a 
large family of compounds that are synthesized from arachidonic acid through the 
cyclooxygenase and lipoxygenase pathways [13]. PGF2α and PGE2 exert opposite 
actions on the corpus luteum (CL); therefore, control over their synthesis and 
secretion is critical either for the initiation of luteolysis or maintenance of preg-
nancy [7, 8].
PGF2α is considered a pro-inflammatory molecule, and it may stimulate 
the synthesis of pro-inflammatory cytokines that enhance phagocytosis and 
lymphocyte functions [14]. PGF2α can increase IL1β, IL6, CCL2, and CXCL8 via 
ERK1/ERK2, PI3K, NFAT, and NF-κB pathways in the myometrial cells from term 
pregnant women, suggesting that PGF2α induces an inflammatory environment 
during the late stage of human pregnancy [15]. PGF2α in vitro enhanced neutro-
phil chemotaxis and the ability of neutrophils to ingest bacteria, and anti-PGF2α 
antibody blocked the chemotactic effects of PGF2α [16, 17]. Exogenous PGF2α 
increases uterine secretion of PGF2α through the activation of phospholipase A2 
(PLA2) and cyclooxygenase 2 [18–20]. Also, it has been proposed that exogenous 
PGF2α increases luteal leukotriene B4 (LTB4) production [21]. LTB4 can stimulate 
chemotaxis, random migration, and antibody-independent cell-mediated cytotox-
icity and may reduce the risk of uterine infections in cows [22].
Most studies about PGF2α and fertility have been performed in production 
animals. PGF2α and its analogs have been used to resolve uterine infections in 
livestock; however, its mechanism of action is not known. Moreover, it is unclear if 
modulation of sexual steroids levels induced by PGF2α directly alters the immune 
response in postpartum. Cattle are resistant to uterine infections when progester-
one concentrations are basal, and they are susceptible to uterine infections when 
progesterone concentrations are increased [23, 24]. It has been proposed that 
exogenous PGF2α is an effective luteolytic factor to reduce progesterone levels 
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and subsequent estrus, with increased estrogen level and myometrial contrac-
tions, and would be favorable for clearance of uterine infection [25, 26]. However, 
other authors report that PGF2α upregulate immune functions reducing vaginal 
discharge, uterine inflammation, endometrium fibrosis, and infection, which could 
be independent of progesterone levels [27]. Also, it has been proposed that PGF2α 
is more effective when progesterone levels are high or a corpus luteum is palpable 
[28, 29]. Thus, a direct effect of PGF2α on immune system has been proposed. The 
in vivo effect of exogenous PGF2α suggests that immune functions do not seem 
entirely independent of progesterone [30]. Fenprostalene, a long-acting PGF2α 
analog, injected between days 7 and 10 postpartum, when progesterone concentra-
tions are basal, reduced the incidence of endometritis in dairy cows with dystocia 
and/or retained fetal membranes and reduced the interval from parturition to 
conception [31]. The studies with cloprostenol and fenprostalene indicate that 
increased PGF2α during the postpartum period in dairy cattle improves uterine 
health [27, 31]. Indeed, jugular concentrations of 13,14-dihydro-15-keto-PGF2α, 
which is a metabolite that seems to reflect uterine production of PGF2α postpar-
tum, were less in postpartum dairy cows that subsequently developed uterine 
infections, than in cows that did not develop uterine infections [31, 32]. Despite the 
above antecedents, the evidence is contradictory if exogenous PGF2α can be useful 
as endometritis therapy in cows [33–36].
PGE2 is the most abundant eicosanoid lipid in the inflammatory environment. 
Thus, PGE2 plays a pivotal role in endometriosis-associated inflammation and 
pain, and its production is augmented in lesions and in the peritoneal cavity [37, 
38]. Exogenous PGE2 pretreatment also modulates the innate immune response, 
increasing the Pam3CSK4-induced inflammatory responses through Toll-like 
receptor (TLR)-2 signaling in bovine endometrial epithelial cells [39]. PGE2 can 
increase the lipopolysaccharide (LPS)-induced response on PKA, ERK1/ERK2, and 
IκBα phosphorylation, as well as COX-2 and IL-6 expression, and downregulate the 
PGE2 receptor 4 (EP4) and TLR4 in bovine endometrial cells [40]. PGE2 via EP2 
and EP4 receptors can reduce the expression of CXCL8, CCL2, and granulocyte 
macrophage colony-stimulating factor (GM-CSF) induced by IL-1β in primary 
human myometrial cells [41]. In human uterine epithelial cells, misoprostol, an 
analog of PGE2, increases cAMP levels via EP4 and reduces the expression of 
antimicrobial peptides such as β-defensins [42].
3.  Effect of omega-3 fatty acids on endometrial function: in vivo and 
in vitro studies
Several studies have suggested that supplementation of omega-3 fatty acids 
during pregnancy is beneficial for establishment and maintenance of pregnancy, 
maintains gestation length and fetal growth, prevents preterm birth, and decreases 
the rate of gestational diabetes [43]. These effects of omega-3 fatty acids have been 
mainly studied in animals such as bovine and ovine; however, some recent studies 
have begun to be performed to demonstrate the beneficial effect of these fatty acids 
in humans and mice. Consumption of omega-3 fatty acids has been associated with 
a reduction of the symptoms and lower risk of developing endometriosis in women, 
a hormone-dependent chronic inflammatory condition [44, 45]. In wild-type mice, 
the administration of EPA reduced the number of endometriotic lesions, similarly 
as was observed in a transgenic mouse model with high levels of omega-3 fatty acids 
[46]. In a rat model of endometriosis, the EPA supplementation reduced the endo-
metriotic lesions and expression of pro-inflammatory gene, suggesting that the EPA 
supplementation might be a strategy for the treatment of endometriosis [47].
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Some studies in vitro have evidenced that the supplementation of mice with 
omega-3 fatty acids increased implantation markers such as laminin and leukemia 
inhibitory factor in endometrial epithelium and stroma, which would encourage 
the endometrium for a favorable environment of implantation [48]. Through an 
abortion mouse model and human stromal cells, it was suggested that omega-3 
fatty acids activate the signaling pathways ERK1/ERK2 and AMPK, which increase 
FOXO1 and GLUT 1 expression, and the increased glucose uptake would be impor-
tant for the maintenance of pregnancy [11].
Several studies in bovines have proposed that omega-3-rich diet improve the 
reproductive performance. It has been described that incorporation of fatty acids of 
omega-3, and also omega-6, in the bovine diet influences some of the reproductive 
process involved in the follicular development [49] and progesterone and PGF2α 
production [50, 51] regulating embryo survival and implantation.
It has been shown that high intake of omega-6 fatty acid induces a change in 
membrane phospholipids, increasing the proportion of arachidonic acid, which 
would favor the synthesis of PG of the series 2, and eicosanoid, so it would turn 
into a pro-inflammatory environment [52]. By contrast, the dietary increase of the 
omega-3 fatty acid especially EPA and DHA would increase the proportion of these 
phospholipids in the cell membranes, which would ultimately result in the decrease 
of the synthesis of the PG series 2, whereby they would act as an anti-inflammatory 
mechanism [52]. Based on the effect of fatty acids on PG secretion, several studies 
conducted in dairy cattle have been addressed to attenuate the endometrium secre-
tion of PG at the time of the embryo-maternal recognition of pregnancy in order 
to improve embryo survival and pregnancy rate [53–55]. Dairy cows supplemented 
with conjugated linoleic acid (CLA) have higher pregnancy rates than their non-
supplemented control group, and the probability of pregnancy increases by up to 
26% and that the interval of first postpartum ovulation was reduced by 8 days [56].
Also, the supplementation of dairy cows with polyunsaturated omega-3 fatty acids 
as EPA can inhibit the synthesis of PGF2α through competition with arachidonic acid 
by COX-1 and COX-2 enzymes or in the case of DHA competing with arachidonic 
acid with the phospholipase A2 enzymes [57]. For this reason, fish meal included 
in the bovine diet could reduce PGF2α and delay regression of the CL, improving 
embryonic survival and female fertility [51]. The supplementation of cows with 
omega-3 fatty acid from the fish meal not only reduces the endometrial concentration 
of arachidonic acid but also increases the concentration of both EPA and omega-3 
fatty acids in the endometrium [58]. When fish meal was included in the diet in a 
study conducted with beef cows (Angus), an increase in EPA and DHA in luteal tissue 
and a reduction of arachidonic acid in the endometrium resulting in an increase in the 
fertility of cows were observed [59]. However, in addition to its effect on PG secre-
tion, some studies have concluded that diets rich in EPA and DHA can have a direct 
effect on the growth of the conceptus per se [60]. Others speculate that the delay on 
CL regression would allow not well-developed embryos to reach their competent size 
to initiate a maternal dialog before the luteolytic secretion of PG [50, 61].
The roles of omega-3 and omega-6 fatty acids on prostaglandin secretion have 
been well documented in in vitro and in vivo studies. The production of PGF2 
α was suppressed in an endometrial cell culture when the culture medium was 
supplemented with omega-3 fatty acids [62]. However, when the medium was 
supplemented with omega-6 fatty acids, the increase in the ratio of omega-6 to 
omega-3 produced an increase of PGF2α [63]. Similarly, in studies conducted 
with dairy cows, the supplementation with different ratio of fatty acids from 
omega-6 to omega-3 altered the secretion on PGF2 α induced by either oxytocin 
[64] or spontaneous [49]. The production of PGE2 induced by LPS also was 
inhibited in the cellular line of bovine endometrium BEND treated with DHA [12]. 
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Additionally, recent evidences show an inhibition of the translocation of the tran-
scription factor NF-κB induced by LPS in BEND cells treated with DHA (Figure 1; 
unpublished data).
4. Mechanisms of action of omega-3 fatty acids in endometrial cells
The first known anti-inflammatory mechanism of omega-3 fatty acids was the 
formation of specialized pro-resolving mediators (SPMs) derived from DHA. The 
enzymatic oxygenation of DHA via 12−/15-lipoxygenase (LOX) and 5-LOX leads 
to the formation of the D-series resolvins (RvD1, RvD2, RvD3, RvD4, RvD5, and 
RvD6), neuroprotectins/protectins, and maresins in different cells [10, 66], and 
resolvins have a potent effect on leukocyte migration and also reduce production 
of pro-inflammatory cytokines [67]. All those evidences have been obtained in dif-
ferent cellular types, but in the uterus or endometrial cells, there are not yet studies 
about formation of SPM.
Two more recent mechanisms have been described in macrophages and 
endothelial cells: (1) binding of DHA to FFA4 receptor/β-arrestin and inhibition 
of TAK1/NF-κB, thus reducing synthesis of pro-inflammatory factors, and (2) 
inhibition of NLRP3 inflammasome. FFA4 receptor is a G-protein-coupled receptor 
with high affinity by DHA described first in the intestine and macrophages. Recent 
studies evidenced the presence of FFA4 receptor in the human, mouse, and bovine 
endometrium [11, 12]. After ligand binding, FFA4 receptor couples to β-arrestin2, 
which is followed by receptor endocytosis and inhibition of TAB1-mediated activa-
tion of TAK1, a protein activated after inflammatory stimuli such as LPS, which 
Figure 1. 
Localization of NF-κB in BEND cells treated with DHA and stimulated with LPS. BEND cells were treated 
with 50 μM DHA for 15 min, and then 1 μg/ml LPS was added and incubated for 30 min. NF-κB was detected 
by immunocytochemistry and epifluorescence microscopy. Magnification 40X [65].
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induce signaling through the NF-κB pathway, thus reducing TNF-α, IL-6, and 
MCP-1 [68, 69]. Other studies have proposed omega-3 fatty acids to reduce the 
NLRP3 inflammasome activation [70–73]. The first evidence proposed two mecha-
nisms dependent on FFA4 receptor to the reduction of inflammasome activation: 
first, DHA stimulation caused FFA4 receptor internalization through β-arrestin2, 
which reduced the initial inflammasome priming step by suppressing the nuclear 
translocation of NF-κB, and second, DHA enhanced autophagy, thereby reducing 
inflammasome complex formation or presenting inflammasome components for 
destruction [73]. Then, it was demonstrated that DHA reduced NLRP3 inflamma-
some expression in hepatocytes [70].
In the endometrium, only two lines of evidences about potential mechanisms 
of action of omega-3 have been studied. In human stromal cells, FFA4 receptor 
promoted decidualization through the upregulation of the GLUT1-mediated glu-
cose uptake and glucose-6-phosphate dehydrogenase-mediated pentose-phosphate 
pathway [11]. In mice, FFA4 receptor protects LPS or RU486-induced abortion 
[11]. In summary, omega-3 fatty acids via FFA4 receptor increase ERK1/ERK2 and 
AMPK signaling and upregulate FOXO1 and GLUT1 expression, which increases 
glucose uptake and activates the pentose-phosphate pathway, promoting decidu-
alization and maintenance of pregnancy. In addition, it was also shown that FFA4 
receptor upregulates the expression of chemokines and cytokines such as CXCL12, 
TGFβ, and IL-15 [11]. In bovine endometrial cells, it was evidenced the presence of 
mRNA and protein of FFA4 receptor as well as an increase of intracellular calcium 
mobilization induced by DHA or a synthetic agonist (TUG891) of FFA4 recep-
tor, which was inhibited by AH7614, a FFA4 receptor antagonist [12]. Also, DHA 
reduced NF-κB activation and PGE2 production induced by LPS; however, AH7614 
did not modify these effects, suggesting that other mechanisms would be involved 
in the anti-inflammatory effect of DHA, which should be studied [12].
5. Perspectives in health and diseases
Until now, omega-3 fatty acids have been only used as dietary supplements, 
or DHA-rich diet has been recommended by their beneficial effects for health. 
However, although the mechanism of action of DHA has begun to be elucidated, 
it has not been recommended yet as an anti-inflammatory drug. The recent stud-
ies have described several possible anti-inflammatory mechanisms and propose 
omega-3 fatty acids as potential treatment for spontaneous abortion for its effect on 
decidualization and the maintenance of pregnancy [11]. Also, omega-3 fatty acids 
would be useful for the prevention and treatment of endometriosis because this dis-
order is characterized by a chronic inflammation [44, 46, 47]. In veterinary medi-
cine, omega-3 fatty acids have potential use in fertility of dairy cows. Omega-3- rich 
supplements have been associated with improved reproductive performance, and 
the recent evidence of the presence of FFA4 receptor in the endometrium [12] could 
contribute to understand the mechanism as omega-3 fatty acids exert its effects, 
and open new possibilities for the prevention and treatment of the endometrial 
inflammation associated with infectious diseases, such as metritis or endometritis.
6. Conclusions
Omega-3 fatty acids have anti-inflammatory effects through different mecha-
nisms, described in macrophages and endothelial cells: formation of SPMs, activa-
tion of the FFA4 receptor, inhibition of TAK1/NF-κB activation, and inflammasome 
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